SCHEMBL8290976

SCHEMBL8290976

CCOC(=O)/C(=N\N)c1ccc(F)nc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.38
MEN1 O00255 6/20 0.38
MAPT P10636 5/20 0.38
NPSR1 Q6W5P4 3/20 0.38
CYP1A2 P05177 2/20 0.38
LMNA P02545 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 3/20 0.35
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
TDP1 Q9NUW8 3/20 0.34
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.34
CTDSP1 Q9GZU7 1/20 0.33
RECQL P46063 1/20 0.33
PTPN1 P18031 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290984 0.81 MAPT (0.43) KMT2AMEN1MAPTNPSR1CYP1A2
SCHEMBL31405406 0.81
SCHEMBL30661105 0.81
SCHEMBL30661103 0.81
SCHEMBL3816678 0.81
SCHEMBL4824489 0.80 NAPRT (0.46) KMT2AMEN1MAPTNPSR1CYP1A2
SCHEMBL26665264 0.77 NAPRT (0.30)
SCHEMBL496670 0.77 TSHR (0.52) KMT2AMEN1MAPTNPSR1CYP1A2
SCHEMBL23289698 0.72 MAPT (0.42) KMT2AMEN1MAPTNPSR1CYP1A2
SCHEMBL14002610 0.72 HSD17B10 (0.38) KMT2AMEN1MAPTNPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446199-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-04 US disclosed
EP-1664043-B1 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2007-11-14 EP disclosed
WO-2005028475-A2 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-03-31 WO disclosed